novartis
Roger Bate: Eclectic booster of corporate views
Submitted by thiru on 20. October 2009 - 16:39The Wellcome Trust convened an "Opinion Formers Conference" on "Counterfeit Medicines: Perspectives and Action" on Monday 26 October 2009. The speakers at this meeting included Dr Hans Hogerzeil, Director of Essential Medicines
Novartis (NVS): Some Examples of Joint Ventures, Partnerships, and Alliances
Wednesday, 29 August 2007
According to the Novartis strategic alliances webpage, the company is engaged in "More than 400 collaborations in over 20 countries, over 120 collaborations with major biotech companies, and over 280 collaborations with academic centers."
Selected Joint Ventures, Partnerships, and Alliances with Big Pharma
Novartis and Bayer Schering AG - PTK/ZK - These two companies initially collaborated in the devel
Novartis games the FDA Priority Review Voucher
Submitted by James Love on 10. April 2009 - 14:08On April 8, 2009, the FDA announced it had awarded Novartis a one-time priority review voucher (PRV) to use towards a future new drug application, for Coartem, a malaria drug. While the PRV was designed as an incentive to develop new drugs, Coartem was developed and put on the market outside the United States years before the PRV legislation was proposed.
KEI Statement on the Novartis Lawsuit in India
Submitted by Staff on 5. August 2007 - 22:00